Polymorphisms and characteristics of studies involved in this meta-analysis

Table 1: Polymorphisms and characteristics of studies involved in this meta-analysis

SNP	First Author	Year	Ethnicity	Genotyping Method	Source of Control	Cancer type	Case			Control
SNP	First Author	Year	Ethnicity	Genotyping Method	Source of Control	Cancer type	TT	TC	CC	TT	TC	CC	P(HWE)
rs2516838	Zhaoet al.	2015	Chinese	Taqman	HB	HCC	33	49	12	47	43	10	0.971
rs2516838	Yuanet al.	2015	Chinese	PCR	HB	TC	261	65	8	628	191	35	0.000
rs2516839	Zhouet al.	2014	Chinese	PCR	PB	HCC	35	76	43	52	78	30	0.937
	Zhaoet al.	2015	Chinese	Taqman	HB	HCC	45	22	27	63	25	12	0.001
	Muet al.	2015	Chinese	PCR	HB	TC	88	154	92	281	387	187	0.014
rs2774276	Zhaoet al.	2015	Chinese	Taqman	HB	HCC	59	32	3	65	32	3	0.692
rs2774276	Muet al.	2015	Chinese	PCR	HB	TC	160	152	22	377	395	82	0.141
rs3737787	Zhouet al.	2014	Chinese	PCR	PB	HCC	63	72	20	89	54	17	0.052
rs3737787	Muet al.	2015	Chinese	PCR	HB	TC	147	144	43	453	303	98	0.000

HWE: Hardy-Weinberg equilibrium; HB: Hospital-based, PB: Population-based, HCC: Hepatocellular Carcinoma, TC: Thyroid cancer